This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

OKYO Pharma Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

OKYO Pharma has been growing earnings at an average annual rate of 39.4%, while the Biotechs industry saw earnings growing at 7.2% annually.

Wichtige Informationen

39.4%

Wachstumsrate der Gewinne

62.4%

EPS-Wachstumsrate

Biotechs Wachstum der Industrie11.5%
Wachstumsrate der Einnahmenn/a
Eigenkapitalrenditen/a
Netto-Margen/a
Letzte Ertragsaktualisierung30 Sep 2022

Jüngste Aktualisierungen vergangener Leistungen

Keine Aktualisierungen

Recent updates

Can OKYO Pharma (LON:OKYO) Afford To Invest In Growth?

Nov 26
Can OKYO Pharma (LON:OKYO) Afford To Invest In Growth?

Is OKYO Pharma (LON:OKYO) In A Good Position To Deliver On Growth Plans?

Jan 27
Is OKYO Pharma (LON:OKYO) In A Good Position To Deliver On Growth Plans?

Here's Why We're Not At All Concerned With OKYO Pharma's (LON:OKYO) Cash Burn Situation

Sep 22
Here's Why We're Not At All Concerned With OKYO Pharma's (LON:OKYO) Cash Burn Situation

We Think OKYO Pharma (LON:OKYO) Can Easily Afford To Drive Business Growth

Mar 17
We Think OKYO Pharma (LON:OKYO) Can Easily Afford To Drive Business Growth

We're Interested To See How OKYO Pharma (LON:OKYO) Uses Its Cash Hoard To Grow

Dec 02
We're Interested To See How OKYO Pharma (LON:OKYO) Uses Its Cash Hoard To Grow

Aufschlüsselung der Einnahmen und Ausgaben

Wie OKYO Pharma Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.


Gewinn- und Umsatzhistorie

LSE:OKYO Einnahmen, Ausgaben und Erträge (GBP Millions)
DatumEinnahmenUmsatzAllgemeine und VerwaltungskostenF&E-Ausgaben
30 Sep 220-703
30 Jun 220-502
31 Mar 220-401
31 Dec 210-401
30 Sep 210-400
30 Jun 210-300
31 Mar 210-300
31 Dec 200-100
30 Sep 200000
30 Jun 200-100
31 Mar 200-100
31 Dec 190-301
30 Sep 190-402
30 Jun 190-402
31 Mar 190-402
31 Dec 180-301
30 Sep 180-201
30 Jun 180-1101
31 Mar 180-2000
31 Dec 170-2000
30 Sep 170-1900
30 Jun 170-1000
31 Mar 170000
31 Dec 160000
30 Sep 160010

Qualität der Erträge: OKYO is currently unprofitable.

Wachsende Gewinnspanne: OKYO is currently unprofitable.


Analyse von freiem Cashflow und Gewinn


Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: OKYO is unprofitable, but has reduced losses over the past 5 years at a rate of 39.4% per year.

Beschleunigtes Wachstum: Unable to compare OKYO's earnings growth over the past year to its 5-year average as it is currently unprofitable

Erträge im Vergleich zur Industrie: OKYO is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-7%).


Eigenkapitalrendite

Hohe Eigenkapitalrendite: OKYO's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Kapitalrendite


Rendite auf das eingesetzte Kapital


Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren